Galapagos | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AstraZeneca USD 5.49B 691M 2024-12
Biogen USD 2.38B 675.8M 2024-12
Genmab DKK 9.86B 3.52B 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
GRIFOLS EUR 979.78M 334.84M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Incyte USD 1.69B 383.72M 2024-12
Merck EUR 3.16B 476M 2024-09
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 6.8B 1.92B 2024-06
UCB EUR 1.57B 1.14B 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Galapagos Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.